FDA approves AstraZeneca's asthma drug

(Reuters) - Anglo-Swedish pharmaceutical firm AstraZeneca Plc on Tuesday said the U.S. Food and Drug Administration approved its drug benralizumab, as an add-on treatment for patients with severe asthma aged 12 years and older.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news